ANNE S HUTCHISON NPI 1417068347

NPI Details

Anne S Hutchison is a hematology and oncology internal medicine in Columbia, SC with 22 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Anne S Hutchison NPI is 1417068347. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF VIRGINIA SCHOOL OF MEDICINE
Graduation Year:2004

The provider's business location address is:

166 STONERIDGE DR
COLUMBIA, SC
ZIP 29210-239
Phone: (803) 461-3000
Fax: (803) 461-4913

The NPI 1417068347 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, granisetron, extended-release, 0.1 mg (HCPCS:J1627)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, gadobutrol, 0.1 ml (HCPCS:A9585)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg (HCPCS:Q5116)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Liver function blood test panel (HCPCS:80076)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, rituximab-arrx, biosimilar, (riabni), 10 mg (HCPCS:Q5123)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Ferritin (blood protein) level (HCPCS:82728)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Red blood count, manual test (HCPCS:85044)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Ct scan of chest with contrast (HCPCS:71260)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Unclassified drugs (HCPCS:J3490)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• X-ray of chest, 2 views (HCPCS:71046)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Magnesium level (HCPCS:83735)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Folic acid level, serum (HCPCS:82746)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Ct scan of chest without contrast (HCPCS:71250)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Mri scan of brain before and after contrast (HCPCS:70553)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Alpha-fetoprotein (afp) level, serum (HCPCS:82105)
• 5% dextrose/water (500 ml = 1 unit) (HCPCS:J7060)
• Complete x-ray of body bones (HCPCS:77075)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Drawing of blood for a medical problem (HCPCS:99195)
• Ct scan of soft tissue of neck with contrast (HCPCS:70491)
• Blood test, clotting time (HCPCS:85610)
• Urinalysis using microscope (HCPCS:81015)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)

The enumeration date for this NPI number is 8/31/2006 and was last updated on 9/15/2010.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: